novartis ‘focusing on high-end, innovative medicines,’ ceo says
Published 1 year ago • 2.3K plays • Length 11:50Download video MP4
Download video MP3
Similar videos
-
0:54
novartis as a focused innovative medicines company
-
6:51
novartis ceo discusses how ai will impact drug development
-
5:53
novartis expects 'strong momentum' going into second half, says ceo vasant narasimhan
-
3:04
novartis ceo: spinoffs will see us succeed as a pure-play innovative medicines company
-
0:46
novartis areas of focus
-
9:32
vasant narasimhan novartis ceo on transforming pharma industry
-
43:50
vasant narasimhan, chief executive officer, novartis | bsr18
-
23:37
reimagining medicine with data & digital | novartis ceo at #vivatech19
-
6:12
novartis ceo: expect continued growth in 2023
-
7:01
novartis ceo: nations pulling back on health care spending ‘has long-term consequences'
-
1:58
novartis raises outlook after sandoz generics spinoff
-
4:17
novartis ceo: we expect our six key drugs to grow ahead of analyst expectations
-
4:17
novartis transformation into a pure-play innovative medicines company
-
3:43
novartis ceo vas narasimhan on the latest research on a breast cancer drug
-
24:07
novartis ceo vas narasimhan on the david rubenstein show
-
0:36
vas narasimhan, ceo of novartis - solving problems with diversity
-
2:10
why novartis is focusing on access to innovative medicines
-
14:55
is novartis stock a buy now!? | novartis (nvs) stock analysis! |
-
0:41
vas narasimhan, ceo of novartis - why is r&d in pharma so complex
-
0:41
vas narasimhan, ceo of novartis - how to ensure scientists remain curious
-
4:54
novartis ceo: confident about continued sales growth for rest of year
-
0:45
novartis ceo: company set to become a pure play, innovative medicine business after sandoz spin off